Man­u­fac­tur­ing roundup: FDA clears the way for more mon­key­pox vac­cines to be re­leased; Dis­cov­ery Life Sci­ence nets ac­qui­si­tion

While the mon­key­pox virus con­tin­ues to rage across the coun­try, more vac­cines are mak­ing their way to the US.

Ac­cord­ing to a re­port from the AP, thou­sands more dos­es of the mon­key­pox and small­pox vac­cine Jyn­neos, man­u­fac­tured by Bavar­i­an Nordic, are ex­pect­ed to soon be shipped to the US af­ter the FDA said they had com­plet­ed an in­spec­tion of a Den­mark-based man­u­fac­tur­ing plant.

More than 1.1 mil­lion dos­es of the vac­cine pur­chased by the US gov­ern­ment are cur­rent­ly sit­ting in Bavar­i­an Nordic’s fa­cil­i­ty. The com­pa­ny pre­vi­ous­ly said that it need­ed au­tho­riza­tion from an on-site FDA in­spec­tion be­fore it could be shipped state­side.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.